" /> Molybdenum cofactor deficiency, type b - CISMeF





Preferred Label : Molybdenum cofactor deficiency, type b;

Symbol : MOCODB;

CISMeF acronym : MOCODB;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Molybdenum cofactor deficiency, complementation group b;

Description : Molybdenum cofactor deficiency is a rare autosomal recessive metabolic disorder characterized by neonatal onset of intractable seizures, opisthotonus, and facial dysmorphism associated with hypouricemia and elevated urinary sulfite levels. Affected individuals show severe neurologic damage and often die in early childhood (summary by Reiss et al., 1999). For a general phenotypic description and a discussion of genetic heterogeneity of MOCOD, see MOCODA (252150), which is clinically indistinguishable from MOCODB.;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the molybdenum cofactor synthesis gene 2 (MOCS2, 603708.0001);

Laboratory abnormalities : Decreased xanthine dehydrogenase activity; Decreased sulfite oxidase activity; Hypouricemia; Molybdenum cofactor deficiency; Increased urinary hypoxanthine; Increased urinary taurine; Increased urinary S-sulfocysteine; Xanthine stones; Increased urinary xanthine;

Prefixed ID : #252160;

Détails


Vous pouvez consulter :


Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.